Aldeyra Therapeutics, Inc. (ALDX)
5.11
-0.51
(-9.07%)
USD |
NASDAQ |
Mar 03, 16:00
5.20
+0.09
(+1.76%)
After-Hours: 05:57
Aldeyra Therapeutics Cash from Investing (TTM) : 47.74M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Assertio Holdings, Inc. | -12.57M |
| MediciNova, Inc. | -0.0029M |
| Altimmune, Inc. | -39.68M |
| AbbVie, Inc. | -6.643B |
| Actinium Pharmaceuticals, Inc. | 0.00 |